Jennifer Sexton

Director/CAS Custom Services

Bio

As part of CAS Custom Services, Jennifer designs individualized client solutions by leveraging CAS content, technology, and subject matter experts to solve complex client R&D and business challenges. Jen joined CAS Custom Services in 2020 after spending over a decade as a strategic account manager. Part of her former role included writing and delivering technical customer training for the CAS STN and CAS SciFinder® software platforms.

Jennifer holds a Master of Science degree in chemistry from the University of Notre Dame. She has a Bachelor of Science degree in chemistry and a Bachelor of Arts degree in psychology from Southwest Minnesota State University. She is a member of the Patent Information Users Group (PIUG) and the American Chemical Society (ACS).

バイオテクノロジー

Creating resilience and efficiency in biotech supply chains

Discover how custom digital solutions can help companies build resilient and efficient biotech supply chains while accelerating innovation.
|記事
Read the CAS Insights article
デジタル研究開発

Emerging trends in global biothreat detection

Learn how emerging trends in AI are impacting CBRNE threat detection and mitigation.
|記事
Read the CAS Insights article
デジタル研究開発

Predicting and countering chemical threats: The strategic role of data-driven technologies

Data-driven technologies play a pivotal role in swift analysis and quick response to chemical threats.
|記事
Read the CAS Insights article
デジタル研究開発

Reducing waste through digital transformation

Learn how digital transformation is reducing waste and creating new revenue streams for companies as they repurpose waste byproducts.
|記事
Read the CAS Insights article
デジタル研究開発

Making pharmaceutical formulation data discoverable

Pharmaceutical manufacturers are investigating ways to cultivate insights from dark formulations data, turning once-hidden knowledge into drug discoveries.
|記事
Read the CAS Insights article
デジタル研究開発

R&D Trends: Maximizing dark data to enhance drug repurposing

As the drug repurposing market grows, pharmaceutical manufacturers are investigating ways to cultivate insights from dark formulations data, turning once hidden insights into drug repurposing innovations.
|記事
Read the CAS Insights article
デジタル研究開発

Digital transformation in the chemical industry: Steps to a sustainable future

Digital initiatives are transforming the chemical industry, allowing for faster innovation and a sustainable future.
|記事
Read the CAS Insights article
デジタル研究開発

Pharma data management: Revealing breakthroughs that lie in darkness

Strategies to unlock dark data in the pharmaceutical industry. Reveal data insights and accelerate innovation through digitization and knowledge management.
|記事
Read the CAS Insights article
デジタル研究開発

Digital transformation in pharma: Improving R&D through digital solutions

Digital initiatives are transforming the pharmaceutical industry, allowing for faster drug development and expanded treatment options.
|記事
Read the CAS Insights article
デジタル研究開発

Dark data: Uncovering hidden R&D value

Research and development teams amass huge quantities of complex data which, if exploited correctly, can be a useful information source to improve decision-making and drive innovation.
|記事
Read the CAS Insights article